While RPL15 was identified during an in vivo genome-wide CRISPR activation screen to identify genes in breast cancer patient-derived CTCs that promote their distant metastasis in mice, the latter was trained on a cohort of normal vs primary tumor and whole blood from patients. Here, RPL15 is linked to neoplasm.